研報掘金丨華鑫證券:首予潮宏基“買入”評級,門店擴張穩步推進
華鑫證券研報指出,潮宏基終端銷售逆勢高增,門店擴張穩步推進。7月,公司推出黃油小熊聯名系列產品,並將其送上《費加羅》中文版雜誌封面,成功出圈,雜誌封面定製款限定小熊開售秒售罄,首發當晚抖音旗艦店實時在線人數破5萬,刷新品牌直播新紀錄。公司緊抓年輕人悅己消費心理,構建起差異化IP矩陣,精準把控從產品上市到銷售爆發全過程節奏,通過挖掘綁定高熱場景提升產品使用價值與情感共鳴,激發消費者主動分享與傳播的熱情,從而引爆社交裂變。公司差異化定位年輕時尚消費羣體品牌,憑藉強大的產品設計能力構建起豐富的產品矩陣,非遺文化融合與潮流IP聯名具備爆款潛力,海外市場拓展順利,未來盈利可觀。首次覆蓋,給予“買入”投資評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.